Evidence map›Paper›PMID 23610701›Full record

ArticleBone & joint research2013

Local inhibition of 5-lipoxygenase enhances bone formation in a rat model.

J A Cottrell, V Keshav, A Mitchell, J P O'Connor

Open access · goldAbstract read
In one paragraph

Article in Bone & joint research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Vanadium Compound Treatment Modulates MC3t3-E1 Osteoblast Function.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

J A CottrellUniversity of Medicine and Dentistry of New Jersey, New Jersey Medical School, Department of Biochemistry & Molecular Biology, Newark, New Jersey, USA.
V Keshav
A Mitchell
J P O'Connor
Rutgers, The State University of New Jersey · USNew Jersey Institute of Technology · US

Funding

Local Modulation of Inflammation to Heal Cranial-facial Bone DefectsR01DE019926 · NIDCR · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI O'CONNOR, J PATRICK, RICCI, JOHN · 2009 to 2012
$2.5M
NIDCR NIH HHS R01 DE019926
6 · The paper itself

Abstract

objectivesRecent studies have shown that modulating inflammation-related lipid signalling after a bone fracture can accelerate healing in animal models. Specifically, decreasing 5-lipoxygenase (5-LO) activity during fracture healing increases cyclooxygenase-2 (COX-2) expression in the fracture callus, accelerates chondrogenesis and decreases healing time. In this study, we test the hypothesis that 5-LO inhibition will increase direct osteogenesis.

methodsBilateral, unicortical femoral defects were used in rats to measure the effects of local 5-LO inhibition on direct osteogenesis. The defect sites were filled with a polycaprolactone (PCL) scaffold containing 5-LO inhibitor (A-79175) at three dose levels, scaffold with drug carrier, or scaffold only. Drug release was assessed in vitro. Osteogenesis was assessed by micro-CT and histology at two endpoints of ten and 30 days.

resultsUsing micro-CT, we found that A-79175, a 5-LO inhibitor, increased bone formation in an apparent dose-related manner.

conclusionsThese results indicate that 5-LO inhibition could be used therapeutically to enhance treatments that require the direct formation of bone.

Indexed as

5-lipoxygenaseA-79175Bone formationBone regenerationFemoral defectRat

Identifiers

PMID23610701
PMCPMC3626215
OpenAlexW2040456896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.